Broad Institute Events Calendar
Sign Up

CBTS-MIT Chemical Biology Joint Supergroup

Wednesday, October 16, 2024 4pm to 5pm

415 Main Street Cambridge, MA 02142

Speaker: Professor Nina Hartrampf, University of Zurich 
Talk Title: New Methods for the Chemical Synthesis of Post-Translationally Modified Peptides and Proteins

Description:The protein MYC is an intrinsically disordered transcription factor that is upregulated in >50% of cancers and engages in numerous protein-protein interactions. These interactions are often regulated through posttranslational modifications (PTMs) within MYC’s N-terminus (transactivation domain), most commonly (poly)phosphorylation. Studying these interactions on a molecular level requires proteins with unique and defined PTM patterns, which are challenging to obtain by recombinant methods. Flow-based solid-phase peptide synthesis (SPPS) could therefore be used to obtain long, uniquely modified MYC peptides to study PTM-dependent binding interactions on a molecular level. A challenge that arose during the chemical synthesis of MYC’s transactivation domain—that is often encountered in SPPS—was the aggregation of growing peptide chains ("difficult sequences”), which can lead to incomplete couplings. Previous research into this sequence-dependent phenomenon was limited by the lack of high-throughput analytical methods, thus impeding systematic analysis. While flow-based SPPS allows for aggregation detection, it has so far not led to the development of tools for its suppression. To enable the synthesis of MYC’s transactivation domain, we developed a “Synthesis Tag” (SynTag) consisting of six arginines connected via a cleavable MeDbz linker. SynTag effectively improves batch- and flow-SPPS of “difficult sequences”, enhances the solubility of the cleaved peptides, and provides direct access to native sequences by hydrolysis, or peptide thioesters for Native Chemical Ligation (NCL). We demonstrate its utility in the first chemical synthesis of the MYC transactivation domain with a single NCL. We envisage SynTag to become a broadly applicable tool that enables the synthesis and study of previously unattainable peptides and proteins.